Everest (US:EG) Globenewswire·2026-01-19 09:11Core Insights - ZS has been recognized as a Leader in the 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® by Everest Group, achieving the highest placement among evaluated providers [1][2] Group 1: Evaluation and Recognition - The 2025 report assessed 30 organizations based on market impact, vision, and capability, with ZS receiving the top position in the Leader category [2] - Leaders in this category are defined by their comprehensive support across commercial activities, including launch planning, pricing, omnichannel marketing, sales enablement, and patient engagement [3] Group 2: ZS's Strengths and Capabilities - ZS's strengths include advanced applications of AI and analytics, with case studies demonstrating their expertise in these areas [4] - The ZAIDYN® platform from ZS provides advanced analytics, recommendations, and insights to enhance field execution and customer engagement strategies [7] - ZS employs a consulting-led approach that combines technology with advisory expertise to support problem definition and cross-functional use case development [7] Group 3: Client Engagement and Market Insights - ZS has a broad client coverage, working with organizations ranging from emerging biotech firms to global pharmaceutical companies [7] - An example of ZS's impact includes a global pharmaceutical company utilizing an AI-enabled training simulator for personalized feedback in commercial training [7] - ZS assisted a medtech company in analyzing consumer behavior in a declining product category, leading to a refreshed commercial strategy and improved customer engagement [7]